Randomised EValuation of Therapies for microvAscuLar Injury in STEACS
Clinical trial NCT06935383 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06935383
- Sponsor
- CorFlow Therapeutics AG
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-01
- Primary completion
- 2027-09-01
- Enrollment
- 250
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.